“May all be happy, may all be healed, may all be at peace and may no one ever suffer."
Cutaneous T-cell lymphoma (CTCL) is a type of non-Hodgkin's lymphoma, which affects the T-cells in the skin. This rare type of lymphoma accounts for less than 2% of all non-Hodgkin's lymphomas.
Symptoms of CTCL can vary depending on the stage and type of lymphoma. In the early stages, individuals may experience skin lesions, rash, and itching. As the disease progresses, it can spread to other organs and cause more severe symptoms, including enlarged lymph nodes, fatigue, weight loss, and fever.
Diagnosis of CTCL typically involves a skin biopsy, in which a sample of skin is examined for the presence of abnormal T-cells. Other tests may be performed to determine the stage of the lymphoma, such as imaging studies to look for tumors.
Treatment of CTCL depends on the stage and type of lymphoma and may involve topical or systemic medications, such as chemotherapy, radiation therapy, or immunotherapy. In some cases, stem cell transplantation may be recommended.
While there is currently no cure for CTCL, treatment can often control symptoms and slow the progression of the disease. It is important for individuals with CTCL to work closely with their healthcare provider to manage their condition and prevent complications.
The exact cause of cutaneous T-cell lymphoma isn't known.
In general, cancer begins when cells develop changes (mutations) in their DNA. A cell's DNA contains instructions that tell a cell what to do. The DNA mutations tell the cells to grow and multiply rapidly, creating many abnormal cells.
In cutaneous T-cell lymphoma, the mutations cause too many abnormal T cells that attack the skin. T cells are part of your immune system, and they normally help your body fight germs. Doctors don't know why the cells attack the skin.
Many treatments are available for people with cutaneous T-cell lymphoma. Which treatments are best for you depends on your particular situation, including the extent or stage of your lymphoma. Most people receive a combination of treatments for cutaneous T-cell lymphoma.
Treatment options may include: